Astec Lifesciences Ltd announced its audited financial results for the year ending March 31, 2025, reporting total income of Rs. 386.9 crore and an EBITDA loss of Rs. 60.6 crore, as compared to Rs. 463.8 crore and Rs. 0.3 crore loss the previous year.